Impact of Vitamin D on Diabetic Kidney Disease in African Americans

Completed · Not applicable

Conditions studied: Diabetic Kidney Disease

In brief

This purpose of this project is to evaluate the effectiveness of vitamin D supplementation over 12 months in vitamin D deficient African American adults with type 2 diabetes.

Key facts

Study ID

NCT01214356

Run by

Medical University of South Carolina

People needed

54

Starts

2010-08-01

Expected to finish

2013-07-01

Last updated by the study team

2018-10-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• African American race
• Diagnosis of Type 2 Diabetes
• Stage 1 or 2 Kidney Disease with detectable microalbuminuria >4.0 (mg/g) 25(OH)D level <20 ng/ml

You may not qualify if…

• Type 1 diabetes
• -> Stage 3 Kidney Disease, or history of dialysis, kidney transplantation or nephrolithiasis
• Unable to provide informed consent or contact information
• Pre-existing calcium or parathyroid condition, including serum calcium >10.2 mg/dL
• Sarcoidosis, active tuberculosis, or malignancy
• Known hypersensitivity to vitamin D or any of its analogues and derivatives
• Current pregnancy or planning to become pregnant in next 15 months

Where it is running

• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.